BioCentury
ARTICLE | Clinical News

IV Debio 1450: Ph II data

January 13, 2017 8:49 PM UTC

Top-line data from 284 evaluable patients with ABSSSIs due to Staphylococcus, including methicillin-sensitive or methicillin-resistant S. aureus (MSSA or MRSA), in the microbiological intent-to-treat ...

BCIQ Company Profiles

Debiopharm Group